$CAAS
CHINA AUTOMOTIVE SYSTEMS INC Stock $caas

$caas Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000141057824000335 Filed on March 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$139.4M	$159.2M	$576.4M
YoY Change	-2.0%	23.58%	8.84%
Cost Of Revenue	$115.3M	$124.5M	$472.6M
YoY Change	-4.39%	19.99%	5.93%
Gross Profit	$24.07M	$34.66M	$103.8M
YoY Change	11.34%	38.46%	24.41%
Gross Profit Margin	17.27%	21.78%	18.0%
Selling, General & Admin	$5.547M	$14.00M	$25.50M
YoY Change	16.71%	-8.87%	-2.36%
% of Gross Profit	23.05%	40.39%	24.58%
Research & Development	$5.312M	$9.315M	$29.18M
YoY Change	-16.87%	-12.42%	-19.19%
% of Gross Profit	22.07%	26.88%	28.13%
Depreciation & Amortization	$5.114M	$5.038M	$18.71M
YoY Change	5.31%	-35.17%	-25.68%
% of Gross Profit	21.25%	14.54%	18.03%
Operating Expenses	$14.93M	$23.32M	$70.29M
YoY Change	2.79%	-10.32%	-11.18%
Operating Profit	$9.651M	$11.34M	$39.25M
YoY Change	24.63%	-1271.8%	393.59%
Interest Expense	$258.0K	$764.0K	$1.021M
YoY Change	3.61%	-36.07%	-29.59%
% of Operating Profit	2.67%	6.74%	2.6%
Other Income/Expense, Net	$2.403M	$672.0K	$5.345M
YoY Change	59.99%	-150.19%	-7.56%
Pretax Income	$11.78M	$15.00M	$48.24M
YoY Change	37.42%	-646.86%	109.39%
Income Tax	$1.743M	$2.133M	$5.137M
% Of Pretax Income	14.79%	14.22%	10.65%
Net Earnings	$8.267M	$10.88M	$37.66M
YoY Change	21.22%	150.67%	77.79%
Net Earnings / Revenue	5.93%	6.84%	6.53%
Basic Earnings Per Share	$0.27		$1.25
Diluted Earnings Per Share	$0.27	$0.36	$1.25
COMMON SHARES
Basic Shares Outstanding	30.19M	30.19M	30.19M
Diluted Shares Outstanding	30.19M		30.19M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$112.6M	$125.7M	$125.7M
YoY Change	13.41%	-6.22%	-6.22%
Cash & Equivalents	$112.6M	$114.7M	$114.7M
Short-Term Investments		$11.08M	$11.08M
Other Short-Term Assets	$38.05M	$900.0K	$56.53M
YoY Change	7.68%	22.62%	12.88%
Inventory	$109.1M	$112.4M	$112.4M
Prepaid Expenses
Receivables	$266.7M	$269.4M	$269.4M
Other Receivables	$0.00	$448.0K	$0.00
Total Short-Term Assets	$570.4M	$564.1M	$564.1M
YoY Change	7.91%	8.33%	8.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$99.40M	$101.4M	$110.9M
YoY Change	-5.28%	-4.92%	-4.95%
Goodwill
YoY Change
Intangibles		$3.900M
YoY Change		200.0%
Long-Term Investments	$59.28M	$68.82M	$68.82M
YoY Change	-8.29%	15.06%	15.06%
Other Assets	$32.42M	$18.21M	$18.21M
YoY Change	68.12%		14.78%
Total Long-Term Assets	$200.2M	$202.4M	$202.4M
YoY Change	0.9%	4.51%	4.51%
TOTAL ASSETS
Total Short-Term Assets	$570.4M	$564.1M	$564.1M
Total Long-Term Assets	$200.2M	$202.4M	$202.4M
Total Assets	$770.7M	$766.4M	$766.4M
YoY Change	6.0%	7.29%	7.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$131.2M	$160.6M	$160.6M
YoY Change	-7.69%	6.62%	6.62%
Accrued Expenses	$44.84M	$44.77M	$21.95M
YoY Change	-2.85%	-7.33%	-0.1%
Deferred Revenue	$8.800M	$8.600M
YoY Change	31.34%	50.88%
Short-Term Debt	$152.2M	$48.01M	$141.0M
YoY Change	6.32%	5.11%	66.84%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$363.7M	$383.7M	$383.7M
YoY Change	-0.16%	5.37%	5.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$1.221M	$1.221M
YoY Change		131.25%	131.25%
Other Long-Term Liabilities	$5.360M	$9.115M	$9.115M
YoY Change	-25.22%	-49.93%	-49.93%
Total Long-Term Liabilities	$5.360M	$10.34M	$10.34M
YoY Change	-25.22%	-44.82%	-44.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$363.7M	$383.7M	$383.7M
Total Long-Term Liabilities	$5.360M	$10.34M	$10.34M
Total Liabilities	$377.8M	$398.0M	$422.0M
YoY Change	-2.43%	2.86%	4.79%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$69.73M	$63.73M
YoY Change	9.4%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$7.695M	$7.695M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$358.4M	$344.5M	$344.5M
YoY Change
Total Liabilities & Shareholders Equity	$770.7M	$766.4M	$766.4M
YoY Change	6.0%	7.29%	7.29%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$8.267M	$10.88M	$37.66M
YoY Change	21.22%	150.67%	77.79%
Depreciation, Depletion And Amortization	$5.114M	$5.038M	$18.71M
YoY Change	5.31%	-35.17%	-25.68%
Cash From Operating Activities	$10.45M	$9.166M	$19.91M
YoY Change	-838.06%	-43.93%	-58.55%
INVESTING ACTIVITIES
Capital Expenditures	$4.493M	$7.060M	$18.24M
YoY Change	42.18%	-17.66%	-10.15%
Acquisitions
YoY Change
Other Investing Activities	-$11.97M	$4.003M	-$6.957M
YoY Change	-11.46%	-78.36%	-43.24%
Cash From Investing Activities	-$16.48M	-$3.057M	-$28.64M
YoY Change	-1.19%	-130.81%	-12.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.985M	12.12M	6.798M
YoY Change	-2101.25%	-1268.56%	-529.44%
NET CHANGE
Cash From Operating Activities	10.45M	9.166M	19.91M
Cash From Investing Activities	-16.48M	-3.057M	-28.64M
Cash From Financing Activities	7.985M	12.12M	6.798M
Net Change In Cash	1.391M	18.23M	-3.757M
YoY Change	-108.66%	-27.76%	585.58%
FREE CASH FLOW
Cash From Operating Activities	$10.45M	$9.166M	$19.91M
Capital Expenditures	$4.493M	$7.060M	$18.24M
Free Cash Flow	$5.958M	$2.106M	$1.671M
YoY Change	-230.2%	-72.9%	-93.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://www.caasauto.com/20231231#EmployeesMember
CY2023Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://www.caasauto.com/20231231#EmployeesMember
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001157762
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-33123
CY2023	dei	Entity Registrant Name EntityRegistrantName	CHINA AUTOMOTIVE SYSTEMS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0885775
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 1 Henglong Road, Yu Qiao Development Zone
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Shashi District
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Jing Zhou City
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Hubei Province
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	434000
CY2023	dei	City Area Code CityAreaCode	86
CY2023	dei	Local Phone Number LocalPhoneNumber	716-412-7901
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2023	dei	Trading Symbol TradingSymbol	CAAS
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	52400000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30185702
CY2023	dei	Auditor Firm AuditorFirmId	1424
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers
CY2023	dei	Auditor Location AuditorLocation	42/F New Bund Center, 588 Dongyu Road, Pudong New Area, Shanghai 200126, PRC
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	true
CY2023Q4	ecd	Trd Arr Securities Agg Avail Amt TrdArrSecuritiesAggAvailAmt	282100
CY2023	ecd	Trd Arr Termination Date TrdArrTerminationDate	August 30, 2024
CY2023	ecd	Trd Arr Adoption Date TrdArrAdoptionDate	April 22, 2008
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	114660000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	121216000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	40534000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	37735000
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	11084000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	12861000
CY2023Q4	us-gaap	Inventory Net InventoryNet	112392000
CY2022Q4	us-gaap	Inventory Net InventoryNet	112236000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	564075000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	520718000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101359000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106606000
CY2023Q4	caas	Rights Of Use Assets Net RightsOfUseAssetsNet	9233000
CY2022Q4	caas	Rights Of Use Assets Net RightsOfUseAssetsNet	9555000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3865000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1273000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	278000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	477000
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8647000
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0
CY2023Q4	caas	Allowance For Non Trade Receivables Non Current AllowanceForNonTradeReceivablesNonCurrent	49000
CY2022Q4	caas	Allowance For Non Trade Receivables Non Current AllowanceForNonTradeReceivablesNonCurrent	50000
CY2023Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	598000
CY2022Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	46000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	60173000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	59810000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8899000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7652000
CY2023Q4	us-gaap	Assets Assets	766440000
CY2022Q4	us-gaap	Assets Assets	714352000
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	48005000
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	45671000
CY2023Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	8633000
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	5654000
CY2023Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	11282000
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	11628000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44771000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	48311000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	17267000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	17598000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	203000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	226000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	383739000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	364195000
CY2023Q4	caas	Advance Payable Non Current AdvancePayableNonCurrent	282000
CY2022Q4	caas	Advance Payable Non Current AdvancePayableNonCurrent	2144000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	52000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	255000
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	1221000
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	528000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3943000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4010000
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	8781000
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	15805000
CY2023Q4	us-gaap	Liabilities Liabilities	398018000
CY2022Q4	us-gaap	Liabilities Liabilities	386937000
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	613000
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	582000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32338302
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32338302
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	63731000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	63731000
CY2023Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	11851000
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	11851000
CY2023Q4	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	284832000
CY2022Q4	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	247174000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8258000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3413000
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2152600
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2152600
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	7695000
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	7695000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	344464000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	311651000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	23345000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	15182000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	367809000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	326833000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	766440000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	714352000
CY2023	us-gaap	Revenues Revenues	576354000
CY2022	us-gaap	Revenues Revenues	529551000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	472603000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	446157000
CY2023	us-gaap	Gross Profit GrossProfit	103751000
CY2022	us-gaap	Gross Profit GrossProfit	83394000
CY2023	caas	Gain Loss On Other Sales GainLossOnOtherSales	5788000
CY2022	caas	Accretion To Redemption Value Of Redeemable Noncontrolling Interest AccretionToRedemptionValueOfRedeemableNoncontrollingInterest	30000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32813000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6949000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	344464000
CY2022	caas	Gain Loss On Other Sales GainLossOnOtherSales	3696000
CY2023	us-gaap	Selling Expense SellingExpense	15610000
CY2022	us-gaap	Selling Expense SellingExpense	16910000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25503000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26120000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29181000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36109000
CY2023	us-gaap	Operating Expenses OperatingExpenses	70294000
CY2022	us-gaap	Operating Expenses OperatingExpenses	79139000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	39245000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	7951000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5345000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5782000
CY2023	us-gaap	Interest Expense InterestExpense	1021000
CY2022	us-gaap	Interest Expense InterestExpense	1450000
CY2023	caas	Finance Income Expenses Net FinanceIncomeExpensesNet	4666000
CY2022	caas	Finance Income Expenses Net FinanceIncomeExpensesNet	10753000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	48235000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23036000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5137000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3082000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-360000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2389000
CY2023	us-gaap	Profit Loss ProfitLoss	42738000
CY2022	us-gaap	Profit Loss ProfitLoss	22343000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5050000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1132000
CY2023	caas	Accretion To Redemption Value Of Redeemable Noncontrolling Interest AccretionToRedemptionValueOfRedeemableNoncontrollingInterest	30000
CY2022	caas	Accretion To Redemption Value Of Redeemable Noncontrolling Interest AccretionToRedemptionValueOfRedeemableNoncontrollingInterest	30000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	37658000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	21181000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.25
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30185702
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30639102
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30189421
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30641274
CY2023	us-gaap	Profit Loss ProfitLoss	42738000
CY2022	us-gaap	Profit Loss ProfitLoss	22343000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5191000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-29934000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	37547000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7591000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4704000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-672000
CY2023	caas	Accretion To Redemption Value Of Redeemable Noncontrolling Interest AccretionToRedemptionValueOfRedeemableNoncontrollingInterest	30000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	311651000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	367809000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	326833000
CY2023	us-gaap	Profit Loss ProfitLoss	42738000
CY2022	us-gaap	Profit Loss ProfitLoss	22343000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18708000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25173000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1319000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1243000
CY2023	caas	Increase Decrease In Allowance For Doubtful Accounts IncreaseDecreaseInAllowanceForDoubtfulAccounts	-1564000
CY2022	caas	Increase Decrease In Allowance For Doubtful Accounts IncreaseDecreaseInAllowanceForDoubtfulAccounts	-4404000
CY2023	caas	Impairment Loss On Prepayment For Acquisition Of Subsidiary ImpairmentLossOnPrepaymentForAcquisitionOfSubsidiary	0
CY2022	caas	Impairment Loss On Prepayment For Acquisition Of Subsidiary ImpairmentLossOnPrepaymentForAcquisitionOfSubsidiary	2676000
CY2023	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-360000
CY2022	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	2389000
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	794000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3000
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-58000
CY2023	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	50699000
CY2022	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	36935000
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3881000
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	41000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1654000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5368000
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	556000
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0
CY2023	caas	Increase Decrease In Accounts And Notes Payable IncreaseDecreaseInAccountsAndNotesPayable	22024000
CY2022	caas	Increase Decrease In Accounts And Notes Payable IncreaseDecreaseInAccountsAndNotesPayable	27271000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3091000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3580000
CY2023	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	77000
CY2022	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1628000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2667000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1158000
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-6835000
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	2925000
CY2023	caas	Increase Or Decrease In Advance Payable IncreaseOrDecreaseInAdvancePayable	-1836000
CY2022	caas	Increase Or Decrease In Advance Payable IncreaseOrDecreaseInAdvancePayable	297000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19906000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48023000
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	68550000
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	80244000
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	63240000
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	75144000
CY2023	caas	Increase Decrease In Other Receivable IncreaseDecreaseInOtherReceivable	0
CY2022	caas	Increase Decrease In Other Receivable IncreaseDecreaseInOtherReceivable	-292000
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	0
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	146000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2790000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1514000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18235000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20296000
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3445000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	188000
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3292000
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3986000
CY2023	caas	Increase Decrease In Equity Method Investments IncreaseDecreaseInEquityMethodInvestments	7729000
CY2022	caas	Increase Decrease In Equity Method Investments IncreaseDecreaseInEquityMethodInvestments	12802000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28637000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32740000
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	64776000
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	51898000
CY2023	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	61437000
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	49917000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2434000
CY2023	caas	Repayments Of Borrowing For Sale And Leaseback Transactions RepaymentsOfBorrowingForSaleAndLeasebackTransactions	0
CY2022	caas	Repayments Of Borrowing For Sale And Leaseback Transactions RepaymentsOfBorrowingForSaleAndLeasebackTransactions	1130000
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3459000
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6798000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1583000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1824000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14248000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3757000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-548000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158951000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	159499000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155194000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158951000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1145000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1492000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	7965000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	4044000
CY2023	caas	Property Plant Equipment Value Recorded For Which Advance Paid PropertyPlantEquipmentValueRecordedForWhichAdvancePaid	2699000
CY2022	caas	Property Plant Equipment Value Recorded For Which Advance Paid PropertyPlantEquipmentValueRecordedForWhichAdvancePaid	2473000
CY2023	caas	Account Payable For Acquiring Property Plant And Equipment AccountPayableForAcquiringPropertyPlantAndEquipment	960000
CY2022	caas	Account Payable For Acquiring Property Plant And Equipment AccountPayableForAcquiringPropertyPlantAndEquipment	985000
CY2023	caas	Operating Lease Assets Acquisition OperatingLeaseAssetsAcquisition	278000
CY2022	caas	Operating Lease Assets Acquisition OperatingLeaseAssetsAcquisition	477000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates</i> - The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company is of the opinion that the significant estimates related to valuation of long term assets and investment, the realizable value of accounts receivable and inventories, the accrual of warranty obligations and the recoverability of deferred tax assets. Actual results could differ from those estimates.</p>
CY2023Q4	caas	Accounts And Financing Receivable Allowance For Credit Loss Current AccountsAndFinancingReceivableAllowanceForCreditLossCurrent	17200000
CY2023Q4	caas	Accounts And Financing Receivable Allowance For Credit Loss Noncurrent AccountsAndFinancingReceivableAllowanceForCreditLossNoncurrent	0
CY2023	caas	Rights Of Use Land Pledged With Net Book Value RightsOfUseLandPledgedWithNetBookValue	4800000
CY2022	caas	Rights Of Use Land Pledged With Net Book Value RightsOfUseLandPledgedWithNetBookValue	5100000
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	300000
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	36572000
CY2023	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Product Warranties</i> - The Company provides for the estimated cost of product warranties when the products are sold. Such estimates of product warranties were based on, among other things, historical experience, product changes, material expenses, service and transportation expenses arising from the manufactured product. Estimates will be adjusted on the basis of actual claims and circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">For the years ended December 31, 2023 and 2022, the warranties activities were as follows (figures are in thousands of USD):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:75.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ended December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b><span style="font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:top;width:75.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at the beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,435</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,572</p></td></tr><tr><td style="vertical-align:top;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Additions during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,941</p></td></tr><tr><td style="vertical-align:top;width:75.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Settlement within the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,676)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,877)</p></td></tr><tr><td style="vertical-align:top;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Foreign currency translation loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (628)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,201)</p></td></tr><tr><td style="vertical-align:top;width:75.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at end of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 30,440</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,435</p></td></tr></table>
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	32435000
CY2023	us-gaap	Standard Product Warranty Accrual Additions From Business Acquisition StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition	11309000
CY2022	us-gaap	Standard Product Warranty Accrual Additions From Business Acquisition StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition	10941000
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	12676000
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	11877000
CY2023	us-gaap	Standard Product Warranty Accrual Foreign Currency Translation Gain Loss StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-628000
CY2022	us-gaap	Standard Product Warranty Accrual Foreign Currency Translation Gain Loss StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-3201000
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	30440000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	32435000
CY2023Q4	caas	Employee Benefit Plan Funded Percentage Local EmployeeBenefitPlanFundedPercentageLocal	0.35
CY2022Q4	caas	Employee Benefit Plan Funded Percentage Local EmployeeBenefitPlanFundedPercentageLocal	0.35
CY2023Q4	caas	Employee Benefit Plan Funded Percentage Foreign EmployeeBenefitPlanFundedPercentageForeign	0.26
CY2022Q4	caas	Employee Benefit Plan Funded Percentage Foreign EmployeeBenefitPlanFundedPercentageForeign	0.26
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Concentration of Credit Risk</i> - Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of trade accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In 2023, the Company’s five largest customers accounted for 40.4% of the Company’s consolidated sales, with one customer accounting for more than 10% of consolidated sales (i.e., 17.2% of consolidated sales, which comprised a total of $99.0 million in sales included in the Hubei Henglong segment (Note 25)).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In 2022, the Company’s five largest customers accounted for 42.8% of the Company’s consolidated sales, with one customer accounting for more than 10% of consolidated sales (i.e., 20.2% of consolidated sales, which comprised a total of $106.9 million in sales included in the Hubei Henglong segment (Note 25)).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At December 31, 2023 and 2022, approximately 7.3% and 8.0% of accounts receivable were from trade transactions with the aforementioned customer (accounting for more than 10% of consolidated sales).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company performs ongoing credit evaluations with respect to the financial condition of its debtors, but does not require collateral. It records a provision for doubtful accounts to cover probable credit losses. Management reviews and adjusts this allowance periodically based on historical experience, current economic conditions, supportable forecasts of future economic conditions and other factors for evaluation of the collectability of outstanding accounts receivable.</p>
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0475
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M18D
CY2023Q4	caas	Notes Receivable Pledged As Collateral NotesReceivablePledgedAsCollateral	11500000
CY2022Q4	caas	Notes Receivable Pledged As Collateral NotesReceivablePledgedAsCollateral	13700000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	16122000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12859000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2002000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5371000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	463000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	967000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	410000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-248000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-1141000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17003000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	16122000
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	8957000
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	4283000
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	3206000
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	3942000
CY2023Q4	caas	Prepayment For Research And Development Service PrepaymentForResearchAndDevelopmentService	1553000
CY2022Q4	caas	Prepayment For Research And Development Service PrepaymentForResearchAndDevelopmentService	748000
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	948000
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1287000
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	448000
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	713000
CY2023Q4	caas	Prepayment For Share Repurchase Program PrepaymentForShareRepurchaseProgram	9000
CY2022Q4	caas	Prepayment For Share Repurchase Program PrepaymentForShareRepurchaseProgram	754000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	900000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	734000
CY2023Q4	caas	Prepaid Expense And Other Assets Gross Current PrepaidExpenseAndOtherAssetsGrossCurrent	16021000
CY2022Q4	caas	Prepaid Expense And Other Assets Gross Current PrepaidExpenseAndOtherAssetsGrossCurrent	12461000
CY2023Q4	caas	Prepaid Expense And Other Assets Allowance For Doubtful Accounts Current PrepaidExpenseAndOtherAssetsAllowanceForDoubtfulAccountsCurrent	22000
CY2022Q4	caas	Prepaid Expense And Other Assets Allowance For Doubtful Accounts Current PrepaidExpenseAndOtherAssetsAllowanceForDoubtfulAccountsCurrent	115000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15999000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12346000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	62760000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	71371000
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	28505000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	24502000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	17123000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	16001000
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	4004000
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	362000
CY2023Q4	us-gaap	Inventory Net InventoryNet	112392000
CY2022Q4	us-gaap	Inventory Net InventoryNet	112236000
CY2023	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	4800000
CY2022	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	4700000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	328363000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	323101000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	226436000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	216495000
CY2023Q4	caas	Accumulated Impairment Long Lived Assets AccumulatedImpairmentLongLivedAssets	568000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101359000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106606000
CY2023	us-gaap	Depreciation Depreciation	17200000
CY2022	us-gaap	Depreciation Depreciation	24200000
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	43300000
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	51600000
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	7055000
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	3756000
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	2340000
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	2266000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9395000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6022000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5530000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4749000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3865000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1273000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000.0
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1006000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	892000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	778000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	734000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	429000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	60173000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	59810000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3943000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4010000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	349000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	7967000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	11371000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	8198000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	8525000
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	7510000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	7506000
CY2023Q4	caas	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Bonus DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBonus	222000
CY2022Q4	caas	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Bonus DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBonus	252000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	1869000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	2163000
CY2023Q4	caas	Deferred Tax Assets Temporary Difference On Revenue Recognition DeferredTaxAssetsTemporaryDifferenceOnRevenueRecognition	1248000
CY2022Q4	caas	Deferred Tax Assets Temporary Difference On Revenue Recognition DeferredTaxAssetsTemporaryDifferenceOnRevenueRecognition	1294000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	3215000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	2175000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	30229000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33635000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18981000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23270000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11248000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10365000
CY2023Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	3943000
CY2022Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	4010000
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2349000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2713000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6292000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6723000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1700000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19000000.0
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8899000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7652000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23270000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22788000
CY2023	caas	Provision For Valuation Allowance ProvisionForValuationAllowance	589000
CY2022	caas	Provision For Valuation Allowance ProvisionForValuationAllowance	5058000
CY2023	caas	Valuation Allowance Recoveries ValuationAllowanceRecoveries	4511000
CY2022	caas	Valuation Allowance Recoveries ValuationAllowanceRecoveries	2721000
CY2023	caas	Valuation Allowance Foreign Currency Translation ValuationAllowanceForeignCurrencyTranslation	-367000
CY2022	caas	Valuation Allowance Foreign Currency Translation ValuationAllowanceForeignCurrencyTranslation	-1855000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18981000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23270000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	48005000
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	45671000
CY2023Q4	caas	Long Term Government Loan LongTermGovernmentLoan	1221000
CY2022Q4	caas	Long Term Government Loan LongTermGovernmentLoan	528000
CY2023Q4	caas	Total Bank And Government Loan TotalBankAndGovernmentLoan	49226000
CY2022Q4	caas	Total Bank And Government Loan TotalBankAndGovernmentLoan	46199000
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	195800000
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	148300000
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	49200000
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	46200000
CY2023Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.026
CY2022Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.029
CY2023Q4	caas	Accounts And Notes Payable Current AccountsAndNotesPayableCurrent	253578000
CY2022Q4	caas	Accounts And Notes Payable Current AccountsAndNotesPayableCurrent	235107000
CY2023Q4	caas	Cash Pledged As Collateral CashPledgedAsCollateral	39300000
CY2022Q4	caas	Cash Pledged As Collateral CashPledgedAsCollateral	37600000
CY2023Q4	caas	Notes Receivable Pledged As Collateral For Notes Payable NotesReceivablePledgedAsCollateralForNotesPayable	11500000
CY2022Q4	caas	Notes Receivable Pledged As Collateral For Notes Payable NotesReceivablePledgedAsCollateralForNotesPayable	13700000
CY2023Q4	caas	Property Plant And Equipment And Land Use Right Pledged As Collateral PropertyPlantAndEquipmentAndLandUseRightPledgedAsCollateral	47400000
CY2022Q4	caas	Property Plant And Equipment And Land Use Right Pledged As Collateral PropertyPlantAndEquipmentAndLandUseRightPledgedAsCollateral	39600000
CY2023Q4	caas	Accrued Expenses Current AccruedExpensesCurrent	10464000
CY2022Q4	caas	Accrued Expenses Current AccruedExpensesCurrent	9652000
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	30440000
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	32435000
CY2022Q4	caas	Payable For Investment PayableForInvestment	2043000
CY2023Q4	caas	Payables For Oversea Transportation And Custom Clearance Current PayablesForOverseaTransportationAndCustomClearanceCurrent	400000
CY2022Q4	caas	Payables For Oversea Transportation And Custom Clearance Current PayablesForOverseaTransportationAndCustomClearanceCurrent	294000
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	424000
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	431000
CY2022Q4	caas	Accrued Interest Current AccruedInterestCurrent	465000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3043000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2991000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44771000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	48311000
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3104000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3470000
CY2023Q4	caas	Tariffs Payable Current TariffsPayableCurrent	3548000
CY2022Q4	caas	Tariffs Payable Current TariffsPayableCurrent	7061000
CY2023Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Current TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent	7024000
CY2022Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Current TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent	5270000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2293000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	680000
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1298000
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1117000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	17267000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	17598000
CY2023Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability	15805000
CY2022Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability	21075000
CY2023Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Current TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent	7024000
CY2022Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Current TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent	5270000
CY2023Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Noncurrent TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent	8781000
CY2022Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Noncurrent TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent	15805000
CY2017Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability	35600000
CY2023Q4	caas	Onetime Transition Tax Payablecurrent OnetimeTransitionTaxPayablecurrent	5300000
CY2022Q4	caas	Onetime Transition Tax Payablecurrent OnetimeTransitionTaxPayablecurrent	2800000
CY2020Q3	caas	Redeemable Noncontrolling Interest Redemption Price Percentage RedeemableNoncontrollingInterestRedemptionPricePercentage	0.06
CY2020Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	500000
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	30000.00
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	30000.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	37500
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.24
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	7500
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.04
CY2022	caas	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.29
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	7500
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.37
CY2023	caas	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22500
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.26
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	caas	Statutory Accounting Practices Statutory Surplus Required Percentage StatutoryAccountingPracticesStatutorySurplusRequiredPercentage	0.10
CY2023	caas	Percentage Of Statutory Surplus Reserve PercentageOfStatutorySurplusReserve	0.50
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	0
CY2023	caas	Statutory Accounting Practices Statutory Capital And Surplus Reserve StatutoryAccountingPracticesStatutoryCapitalAndSurplusReserve	0
CY2022	caas	Statutory Accounting Practices Statutory Capital And Surplus Reserve StatutoryAccountingPracticesStatutoryCapitalAndSurplusReserve	400000
CY2018Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000.0
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	666074
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	0
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2400000
CY2023	caas	Income From Government Subsidies IncomeFromGovernmentSubsidies	3777000
CY2022	caas	Income From Government Subsidies IncomeFromGovernmentSubsidies	6270000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	1465000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	1912000
CY2023	caas	Charity Donation1 CharityDonation1	103000
CY2022	caas	Charity Donation1 CharityDonation1	140000
CY2022	caas	Investment Income Loss Expenses InvestmentIncomeLossExpenses	-2540000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5345000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5782000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	18000000.0
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	3355000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	9833000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1524000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1247000
CY2023	caas	Handling Charge HandlingCharge	213000
CY2022	caas	Handling Charge HandlingCharge	327000
CY2023	caas	Finance Income Expenses Net FinanceIncomeExpensesNet	4666000
CY2022	caas	Finance Income Expenses Net FinanceIncomeExpensesNet	10753000
CY2023	caas	Percentage Owned In Holding Company To Avail Withholding Tax Of Five Percent PercentageOwnedInHoldingCompanyToAvailWithholdingTaxOfFivePercent	0.25
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.15
CY2008Q1	caas	Withholding Tax Percentage Applicable To Foreign Investors As Non Resident Enterprises WithholdingTaxPercentageApplicableToForeignInvestorsAsNonResidentEnterprises	0.10
CY2023	caas	Description Of Withholding Tax Rate On Dividend DescriptionOfWithholdingTaxRateOnDividend	Genesis, the Company’s wholly-owned subsidiary and the direct holder of the equity interests in the Company’s subsidiaries in China, is incorporated in Hong Kong. According to the Mainland China and Hong Kong Taxation Arrangement, dividends paid by a foreign-invested enterprise in China to its direct holding company in Hong Kong would be subject to withholding tax at a rate of 10% if Genesis could not obtain the Hong Kong tax resident certificate from the Hong Kong Inland Revenue Department. If Genesis obtains the Hong Kong tax resident certificate, owns directly at least 25% of the shares of the foreign invested enterprise and is qualified as the beneficial owner, it could benefit from a lower rate of 5%.
CY2023	caas	Increase In Income Tax Expense Benefit Percentage IncreaseInIncomeTaxExpenseBenefitPercentage	0.25
CY2023	us-gaap	Undistributed Earnings UndistributedEarnings	302100000
CY2022	us-gaap	Undistributed Earnings UndistributedEarnings	270400000
CY2023	caas	Tax Provision On Retained Earning Not Reinvested TaxProvisionOnRetainedEarningNotReinvested	30200000
CY2022	caas	Tax Provision On Retained Earning Not Reinvested TaxProvisionOnRetainedEarningNotReinvested	27000000.0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	caas	Effective Income Tax Rate Reconciliation Transition Tax Amount EffectiveIncomeTaxRateReconciliationTransitionTaxAmount	35600000
CY2017	caas	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Transition Tax On Accumulated Foreign Earnings Amount1 EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActTransitionTaxOnAccumulatedForeignEarningsAmount1	35100000
CY2018	caas	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Adjustment One Time Transition Tax EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017AdjustmentOneTimeTransitionTax	500000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	48235000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23036000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	10129000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4838000
CY2023	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	5674000
CY2022	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	7089000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1669000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	599000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	3228000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	0
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-293000
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	2597000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5137000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3082000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	37658000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	21181000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30185702
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30639102
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3719
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2172
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30189421
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30641274
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.25
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.25
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2023	caas	Minimum Percentage Of Profit Allocated To Foreign Investment MinimumPercentageOfProfitAllocatedToForeignInvestment	0.10
CY2023	caas	Registered Capital Percentage RegisteredCapitalPercentage	0.50
CY2023Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	20498000
CY2023Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	6333000
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	26831000
CY2023Q4	caas	Number Of Product Sectors NumberOfProductSectors	15
CY2023Q4	caas	Number Of Principal Profit Makers NumberOfPrincipalProfitMakers	6
CY2023Q4	caas	Number Of Holding Company NumberOfHoldingCompany	1
CY2023Q4	caas	Number Of Sectors Engaged In Production And Sale Of Products NumberOfSectorsEngagedInProductionAndSaleOfProducts	9
CY2022Q4	caas	Number Of Product Sectors NumberOfProductSectors	15
CY2022Q4	caas	Number Of Principal Profit Makers NumberOfPrincipalProfitMakers	6
CY2022Q4	caas	Number Of Holding Company NumberOfHoldingCompany	1
CY2022Q4	caas	Number Of Sectors Engaged In Production And Sale Of Products NumberOfSectorsEngagedInProductionAndSaleOfProducts	9
CY2023	caas	Sales Revenues Net SalesRevenuesNet	576354000
CY2022	caas	Sales Revenues Net SalesRevenuesNet	529551000
CY2023	us-gaap	Profit Loss ProfitLoss	42738000
CY2022	us-gaap	Profit Loss ProfitLoss	22343000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18708000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25173000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	21680000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	20484000
CY2023Q4	us-gaap	Assets Assets	766440000
CY2022Q4	us-gaap	Assets Assets	714352000
CY2023	caas	Sales Revenues Net SalesRevenuesNet	576354000
CY2022	caas	Sales Revenues Net SalesRevenuesNet	529551000
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	129428000
CY2022Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	124899000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8900000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7700000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3900000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1300000

Files In Submission

Name	View Source	Status
0001410578-24-000335-index-headers.html	Edgar Link	pending
0001410578-24-000335-index.html	Edgar Link	pending
0001410578-24-000335.txt	Edgar Link	pending
0001410578-24-000335-xbrl.zip	Edgar Link	pending
caas-20231231.xsd	Edgar Link	pending
caas-20231231x10k.htm	Edgar Link	pending
caas-20231231xex23d1.htm	Edgar Link	pending
caas-20231231xex31d1.htm	Edgar Link	pending
caas-20231231xex31d2.htm	Edgar Link	pending
caas-20231231xex32d1.htm	Edgar Link	pending
caas-20231231xex32d2.htm	Edgar Link	pending
caas-20231231xex3d1iii.htm	Edgar Link	pending
caas-20231231xex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
caas-20231231_def.xml	Edgar Link	unprocessable
caas-20231231_lab.xml	Edgar Link	unprocessable
caas-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
caas-20231231x10k_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
caas-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAAS
CHINA AUTOMOTIVE SYSTEMS INC Stock $caas

2024 Q1 Form 10-K Financial Statement

#000141057824000335 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAAS CHINA AUTOMOTIVE SYSTEMS INC Stock $caas

2024 Q1 Form 10-K Financial Statement

#000141057824000335 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAAS
CHINA AUTOMOTIVE SYSTEMS INC Stock $caas